-
In a court filing, the administration says it has no timeline on whether it will allow states to import drugs from Canada, an effort approved under President Donald Trump as a strategy to control costs.
-
If the bankruptcy plan is approved, Florida could get up to $280 million to $400 million over a 10-year period.
-
Critics say the settlement doesn't hold company executives or members of the Sackler family accountable for their aggressive marketing of OxyContin, which helped fuel the nation's opioid epidemic.
-
Don’t worry. Future COVID-19 vaccinations will be affordable and available. That was the message that Lori M. Reilly, chief operating officer of the…
-
The order, which would include Medicare parts B and D, replaces a previous order the president signed in July, but the move is unlikely to have any immediate practical impact.
-
In a business driven by profit, vaccines have a problem. They’re not very profitable — at least not without government subsidies. Pharma companies favor…
-
Thousands of lawsuits that ground to a halt because of COVID-19 are moving forward again as local, state and federal courts reopen around the U.S.
-
It's been two weeks since the president signed an executive order to put "America First" on drug prices. But pharmaceutical companies aren't ready to negotiate.
-
The president says the actions will lower drug prices, but policy experts say they will likely offer patients only minimal relief and may take months to implement, if they're implemented at all.
-
John Kapoor, the former billionaire who founded drugmaker Insys Therapeutics, is among the executives to be sentenced for racketeering.